Spartan Micro has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for Spartan eCoil System.
FREMONT, CALIFORNIA, UNITED STATES, December 5, 2018 /EINPresswire.com/ — December 5, 2018—Spartan Micro, Inc. (Fremont, CA), a developer of endovascular-based devices for use by interventional radiologist, has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for Spartan eCoil System.
The endovascular Spartan eCoil System is an embolization coil line that is designed to occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. The system is a comprehensive bare platinum coil line available in framing, filling, and finishing shapes.
“We are very pleased to have received FDA clearance for the Spartan eCoil system. We look forward to submitting our complete product line for FDA clearance in the near future,” said Mark Dias, Spartan Micro’s CTO.
"This is a significant achievement of our team as we continue the successful commercialization of the Spartan eCoil System and other products in the future," added Eric Stoppenhagen, Spartan Micro's President.
Source: EIN Presswire